Cravatex Intrinsic Value

CRAVATEX • Commercial Services
Current Stock Price
₹371.05
Primary Intrinsic Value
₹968.64
Market Cap
₹111.3 Cr
+58.1% Upside
Median Value
₹586.67
Value Range
₹148 - ₹969
Assessment
Trading Below Calculated Value
Safety Margin
36.8%

CRAVATEX Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹968.64 ₹774.91 - ₹1162.37 +161.1% EPS: ₹80.72, Sector P/E: 12x
Book Value Method asset ₹353.33 ₹318.00 - ₹388.66 -4.8% Book Value/Share: ₹353.33, P/B: 1.0x
Revenue Multiple Method revenue ₹586.67 ₹528.00 - ₹645.34 +58.1% Revenue/Share: ₹733.33, P/S: 0.8x
EBITDA Multiple Method earnings ₹560.00 ₹504.00 - ₹616.00 +50.9% EBITDA: ₹28.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹148.42 ₹118.74 - ₹178.10 -60.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹516.61 ₹464.95 - ₹568.27 +39.2% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹665.13 ₹598.62 - ₹731.64 +79.3% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹742.10 ₹667.89 - ₹816.31 +100.0% ROE: 18.9%, P/E Multiple: 14x
Graham Defensive Method conservative ₹706.67 ₹636.00 - ₹777.34 +90.5% EPS: ₹80.72, BVPS: ₹353.33
Dividend Yield Method dividend ₹357.14 ₹321.43 - ₹392.85 -3.7% DPS: ₹12.50, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check CRAVATEX share price latest .

Valuation Comparison Chart

CRAVATEX Intrinsic Value Analysis

What is the intrinsic value of CRAVATEX?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Cravatex (CRAVATEX) is ₹586.67 (median value). With the current market price of ₹371.05, this represents a +58.1% variance from our estimated fair value.

The valuation range spans from ₹148.42 to ₹968.64, indicating ₹148.42 - ₹968.64.

Is CRAVATEX undervalued or overvalued?

Based on our multi-method analysis, Cravatex (CRAVATEX) appears to be trading below calculated value by approximately 58.1%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 43.67 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.33 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 18.9% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 5.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.56x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2024 ₹19 Cr ₹19 Cr Positive Free Cash Flow 8/10
March 2023 ₹144 Cr ₹144 Cr Positive Free Cash Flow 8/10
March 2022 ₹-8 Cr ₹-8 Cr Negative Cash Flow 3/10
March 2021 ₹-4 Cr ₹-4 Cr Negative Cash Flow 3/10